Thomas Klima
Chief Operating Officer at BLUEBIRD BIO, INC.
Net worth: 113 979 $ as of 2024-04-29
Thomas Klima active positions
| Companies | Position | Start | End |
|---|---|---|---|
| BLUEBIRD BIO, INC. | Chief Operating Officer | 2022-08-07 | - |
| Corporate Officer/Principal | 2021-05-09 | 2022-08-07 |
Career history of Thomas Klima
Former positions of Thomas Klima
| Companies | Position | Start | End |
|---|---|---|---|
| GAMIDA CELL LTD. | Corporate Officer/Principal | 2019-01-06 | 2020-11-30 |
| NAVIDEA BIOPHARMACEUTICALS, INC. | Corporate Officer/Principal | 2015-01-04 | 2017-03-07 |
| DENDREON CORPORATION | Sales & Marketing | 2009-08-31 | 2012-08-31 |
Training of Thomas Klima
| Western State College of Colorado | Undergraduate Degree |
Statistics
International
| United States | 6 |
Operational
| Corporate Officer/Principal | 3 |
| Undergraduate Degree | 1 |
| Sales & Marketing | 1 |
Sectoral
| Health Technology | 5 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 3 |
|---|---|
| NAVIDEA BIOPHARMACEUTICALS, INC. | Health Technology |
| GAMIDA CELL LTD. | Health Technology |
| BLUEBIRD BIO, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Dendreon Corp.
 Dendreon Corp. Medical SpecialtiesHealth Technology Dendreon Corp. discovers, develops and commercializes novel products for the treatment of cancer. The company applies its expertise in antigen identification, engineering and cell processing to produce active cellular immunotherapy ACI product candidates designed to stimulate an immune response in a variety of tumor types. It is an exploring the application of additional ACI product candidates and small molecules for the potential treatment of a variety of cancers. Dendreon was founded by Christopher S. Henney, Edgar G. Engleman and Samuel Strober in 1992 and is headquartered in Seattle, WA. | Health Technology |
- Stock Market
- Insiders
- Thomas Klima
- Experience